{
  "trial_id": "NCT04447872",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "stimulation cycles as will be described",
      "label": "met"
    },
    {
      "criterion": "Luteal Phase Ovarian Stimulation (LPOS)",
      "label": "met"
    },
    {
      "criterion": "Patients will present for an appointment on approximately day 15-18 of her menstrual cycle",
      "label": "met"
    },
    {
      "criterion": "If serum progesterone >3 ng/mL, and bHCG < 5 mIU/mL, the patient will begin 450 IU of daily injectable gonadotropins: 150 IU of hMG (Menopur\u00ae, Ferring Pharmaceuticals) and 300 IU of recombinant FSH (rFSH) (Gonal F\u00ae,Serono; or Follitropin beta (Follistim\u00ae, Organo)).",
      "label": "met"
    },
    {
      "criterion": "She will present for follicular monitoring ultrasound and serum blood tests on stimulation day 3-4, 5-6, and 7-8-~15.",
      "label": "unknown"
    },
    {
      "criterion": "Gonadotropin releasing hormone (GnRH) antagonist (Ganirelix, Organon; and cetrorelix, Serono) will be started daily once either (1) serum estradiol level reaches > 400 pg/mL, lead follicle size > 13mm, or (2) on stimulation day 6.",
      "label": "unknown"
    },
    {
      "criterion": "Once patient are ready for ovulation trigger as determine by physician, 5-10,000 units of human chorionic gonadotropin (Novarel\u00ae: Ferring Pharmaceuticals; or Pregnyl\u00ae: Schering-Plough) will be administered.",
      "label": "unknown"
    },
    {
      "criterion": "A patient's trigger shot could be changed to include a GnRH agonist (i.e Luprolide acetate 40 IU) if deemed clinically necessary for ovarian hyperstimulation syndrome prevention.",
      "label": "unknown"
    },
    {
      "criterion": "On the morning after hCG administration, patients' blood will be drawn and serum analyzed for hCG concentration to ensure adequate absorption (mean time 8-10 hours).",
      "label": "unknown"
    },
    {
      "criterion": "Transvaginal oocyte retrieval will be performed 35 to 37 hours after hCG trigger.",
      "label": "unknown"
    },
    {
      "criterion": "All metaphase II oocytes will be fertilized with intracytoplasmic sperm injection (ICSI) or IVF per patient request and laboratory protocol.",
      "label": "unknown"
    },
    {
      "criterion": "Embryos will be cultured to the blastocyst stage and vitrified on day 5-7.",
      "label": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients who will be undergoing controlled ovarian stimulation and who have a diagnosis of diminished ovarian reserve",
      "label": "triggers"
    },
    {
      "criterion": "Oocyte donation cycle",
      "label": "unknown"
    },
    {
      "criterion": "Oocyte freezing cycle",
      "label": "unknown"
    },
    {
      "criterion": "Current ovarian cyst > 3cm",
      "label": "triggers"
    },
    {
      "criterion": "Anovulatory or oligo-ovulatory (<6 ovulation per year)",
      "label": "triggers"
    },
    {
      "criterion": "Previous oophorectomy",
      "label": "unknown"
    },
    {
      "criterion": "Exposure to cytotoxic or pelvic irradiation",
      "label": "triggers"
    }
  ],
  "notes": "",
  "_meta": {
    "topic_id": "66",
    "trial_id": "NCT04447872",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}